vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and EXTREME NETWORKS INC (EXTR). Click either name above to swap in a different company.

AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $317.9M, roughly 1.1× EXTREME NETWORKS INC). EXTREME NETWORKS INC runs the higher net margin — 2.5% vs -0.8%, a 3.3% gap on every dollar of revenue. On growth, EXTREME NETWORKS INC posted the faster year-over-year revenue change (13.8% vs 9.4%). EXTREME NETWORKS INC produced more free cash flow last quarter ($43.0M vs $36.1M). Over the past eight quarters, EXTREME NETWORKS INC's revenue compounded faster (22.7% CAGR vs 3.4%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Extreme Networks, Inc. is an American networking company based in Morrisville, North Carolina. Extreme Networks designs, develops, and manufactures wired and wireless network infrastructure equipment and develops the software for network management, policy, analytics, security and access controls.

ASIX vs EXTR — Head-to-Head

Bigger by revenue
ASIX
ASIX
1.1× larger
ASIX
$359.9M
$317.9M
EXTR
Growing faster (revenue YoY)
EXTR
EXTR
+4.4% gap
EXTR
13.8%
9.4%
ASIX
Higher net margin
EXTR
EXTR
3.3% more per $
EXTR
2.5%
-0.8%
ASIX
More free cash flow
EXTR
EXTR
$6.9M more FCF
EXTR
$43.0M
$36.1M
ASIX
Faster 2-yr revenue CAGR
EXTR
EXTR
Annualised
EXTR
22.7%
3.4%
ASIX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ASIX
ASIX
EXTR
EXTR
Revenue
$359.9M
$317.9M
Net Profit
$-2.8M
$7.9M
Gross Margin
7.6%
61.4%
Operating Margin
-0.7%
4.1%
Net Margin
-0.8%
2.5%
Revenue YoY
9.4%
13.8%
Net Profit YoY
-892.9%
6.7%
EPS (diluted)
$-0.11
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
EXTR
EXTR
Q4 25
$359.9M
$317.9M
Q3 25
$374.5M
$310.2M
Q2 25
$410.0M
$307.0M
Q1 25
$377.8M
$284.5M
Q4 24
$329.1M
$279.4M
Q3 24
$398.2M
$269.2M
Q2 24
$453.5M
$256.7M
Q1 24
$336.8M
$211.0M
Net Profit
ASIX
ASIX
EXTR
EXTR
Q4 25
$-2.8M
$7.9M
Q3 25
$-2.6M
$5.6M
Q2 25
$31.4M
$-7.8M
Q1 25
$23.3M
$3.5M
Q4 24
$352.0K
$7.4M
Q3 24
$22.3M
$-10.5M
Q2 24
$38.9M
$-54.2M
Q1 24
$-17.4M
$-64.4M
Gross Margin
ASIX
ASIX
EXTR
EXTR
Q4 25
7.6%
61.4%
Q3 25
6.8%
60.6%
Q2 25
14.3%
61.6%
Q1 25
14.2%
61.7%
Q4 24
3.4%
62.7%
Q3 24
14.4%
63.0%
Q2 24
17.9%
44.7%
Q1 24
0.9%
56.8%
Operating Margin
ASIX
ASIX
EXTR
EXTR
Q4 25
-0.7%
4.1%
Q3 25
-0.9%
3.6%
Q2 25
7.7%
-0.4%
Q1 25
7.7%
3.6%
Q4 24
-3.9%
4.5%
Q3 24
7.5%
-1.8%
Q2 24
11.5%
-19.1%
Q1 24
-7.0%
-29.6%
Net Margin
ASIX
ASIX
EXTR
EXTR
Q4 25
-0.8%
2.5%
Q3 25
-0.7%
1.8%
Q2 25
7.7%
-2.5%
Q1 25
6.2%
1.2%
Q4 24
0.1%
2.6%
Q3 24
5.6%
-3.9%
Q2 24
8.6%
-21.1%
Q1 24
-5.2%
-30.5%
EPS (diluted)
ASIX
ASIX
EXTR
EXTR
Q4 25
$-0.11
$0.06
Q3 25
$-0.10
$0.04
Q2 25
$1.15
$-0.07
Q1 25
$0.86
$0.03
Q4 24
$0.02
$0.06
Q3 24
$0.82
$-0.08
Q2 24
$1.43
$-0.40
Q1 24
$-0.65
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
EXTR
EXTR
Cash + ST InvestmentsLiquidity on hand
$19.8M
$219.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$815.2M
$95.9M
Total Assets
$1.7B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
EXTR
EXTR
Q4 25
$19.8M
$219.8M
Q3 25
$23.7M
$209.0M
Q2 25
$18.4M
$231.7M
Q1 25
$8.3M
$185.5M
Q4 24
$19.6M
$170.3M
Q3 24
$17.3M
$159.5M
Q2 24
$12.1M
$156.7M
Q1 24
$20.6M
$151.0M
Total Debt
ASIX
ASIX
EXTR
EXTR
Q4 25
Q3 25
Q2 25
$180.0M
Q1 25
Q4 24
Q3 24
Q2 24
$190.0M
Q1 24
Stockholders' Equity
ASIX
ASIX
EXTR
EXTR
Q4 25
$815.2M
$95.9M
Q3 25
$818.2M
$68.6M
Q2 25
$823.7M
$65.6M
Q1 25
$794.4M
$71.7M
Q4 24
$774.6M
$51.2M
Q3 24
$766.4M
$32.7M
Q2 24
$746.6M
$25.3M
Q1 24
$713.2M
$65.0M
Total Assets
ASIX
ASIX
EXTR
EXTR
Q4 25
$1.7B
$1.2B
Q3 25
$1.7B
$1.2B
Q2 25
$1.6B
$1.2B
Q1 25
$1.6B
$1.1B
Q4 24
$1.6B
$1.1B
Q3 24
$1.5B
$1.1B
Q2 24
$1.5B
$1.0B
Q1 24
$1.5B
$1.1B
Debt / Equity
ASIX
ASIX
EXTR
EXTR
Q4 25
Q3 25
Q2 25
2.74×
Q1 25
Q4 24
Q3 24
Q2 24
7.52×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
EXTR
EXTR
Operating Cash FlowLast quarter
$63.7M
$50.1M
Free Cash FlowOCF − Capex
$36.1M
$43.0M
FCF MarginFCF / Revenue
10.0%
13.5%
Capex IntensityCapex / Revenue
7.7%
2.2%
Cash ConversionOCF / Net Profit
6.37×
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$121.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
EXTR
EXTR
Q4 25
$63.7M
$50.1M
Q3 25
$26.6M
$-14.0M
Q2 25
$21.1M
$81.9M
Q1 25
$11.4M
$30.0M
Q4 24
$64.2M
$21.5M
Q3 24
$57.3M
$18.6M
Q2 24
$50.2M
$15.5M
Q1 24
$-36.2M
$-69.9M
Free Cash Flow
ASIX
ASIX
EXTR
EXTR
Q4 25
$36.1M
$43.0M
Q3 25
$66.0K
$-20.9M
Q2 25
$-7.2M
$75.3M
Q1 25
$-22.6M
$24.2M
Q4 24
$29.8M
$16.1M
Q3 24
$26.8M
$11.7M
Q2 24
$16.7M
$11.0M
Q1 24
$-71.6M
$-73.5M
FCF Margin
ASIX
ASIX
EXTR
EXTR
Q4 25
10.0%
13.5%
Q3 25
0.0%
-6.7%
Q2 25
-1.7%
24.5%
Q1 25
-6.0%
8.5%
Q4 24
9.1%
5.8%
Q3 24
6.7%
4.3%
Q2 24
3.7%
4.3%
Q1 24
-21.3%
-34.8%
Capex Intensity
ASIX
ASIX
EXTR
EXTR
Q4 25
7.7%
2.2%
Q3 25
7.1%
2.2%
Q2 25
6.9%
2.2%
Q1 25
9.0%
2.0%
Q4 24
10.4%
1.9%
Q3 24
7.7%
2.6%
Q2 24
7.4%
1.7%
Q1 24
10.5%
1.7%
Cash Conversion
ASIX
ASIX
EXTR
EXTR
Q4 25
6.37×
Q3 25
-2.49×
Q2 25
0.67×
Q1 25
0.49×
8.67×
Q4 24
182.29×
2.92×
Q3 24
2.57×
Q2 24
1.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

EXTR
EXTR

Products$197.8M62%
Subscription And Support$120.2M38%

Related Comparisons